The North America cell therapy instruments market was valued at US$ 5,546.84 million in 2019 and is projected to reach US$ 14,806.33 million by 2027; it is expected to grow at a CAGR of 13.4% during the forecast period.
The rise in cell therapy transplantation's, growing numbers of research and development activities and rising investments for building cell and gene therapy manufacturing plants will drive the growth of the North America cell therapy instruments market during the forecast period. However, the high cost of low success rate and cell-based research are expected to restrain North America Cell Therapy Instruments market growth during the forecast period.
Cell therapy is the therapy involving administration of somatic cell preparations by injecting or grafting into the patient’s body for the treatment of diseases or traumatic damages. Various instruments are used to carry out cell therapy to cure diabetes, neurological disorders, related injuries, some types of cancer, bones and joints and genetic disorders.
The increasing research and development in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to improve immune system and efficiently treat genetic disorders. Various market players provide several consumables such as reagents kits and enzymes and many companies offer instruments, equipment, and software to conduct a wide range of cell therapy processes.
The use of equipment is important for the production of cell therapies such as NSC, PSC, MSC, T cells and HSC, . These cell therapy products are derived from animals or human cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies helps in preventing contamination and allows scaling up the transplantation. For instance, companies such as Hitachi Chemical Advanced Therapeutics Solutions, Corning Incorporated, Thermo Fisher Scientific Inc., Miltenyi Biotec, LLC, Invetech and Cytiva (General Electric Company) have introduced various equipment and consumables for the cell therapy.
Across North America, various healthcare research centers were working only for research on COVID 19 therapeutics. Additionally, during the initial phase of COVID-19 crisis, due to lockdown and supply chain disruptions the demand for cell therapy instruments was disrupted owing to change in customer behaviors. However, in long run cell therapy instruments market will have significant growth prospects. For instance, lack of definitive therapy offers significant opportunities for cell therapy instrumentation market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients.
North America Cell Therapy Instruments Market Revenue and Forecast to 2027 (US$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Cell Therapy Instruments Market
By Product
- Consumables
- Equipment
- Single-Use Equipment
- Cell Processing Equipment
- Other Equipment
- Systems and Software
By Cell Type
- Human Cells
- Differentiated Cells
- Stem Cells
- Animal Cells
By Process
- Cell Processing
- Process Monitoring and Quality Control
- Cell Preservation, Distribution, and Handling
By End User
- Research Institutes
- Life Science Research Companies
- Other End Users
By Geography
- US
- Canada
- Mexico
List of Companies
- STEMCELL Technologies Inc.
- Miltenyi Biotec
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
North America Cell Therapy Instruments Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 5,546.84 Million |
Market Size by 2027 | US$ 14,806.33 Million |
Global CAGR (2019 - 2027) | 13.4% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- STEMCELL Technologies Inc.
- Miltenyi Biotec
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA


